Skip to main content

Table 1 Baseline characteristics of the 90 study participants

From: Hepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjects

  Inclusion groups
Centre of Obesity Sixth Tromsø Study
N Median (SD) Range N Median (SD) Range
Age, years 22 43.0 (12.76) 21–69 68 66.0 (10.84) 32–82
Height, cm 22 167.5 (6.87) 156–179 68 166.0 (9.08) 141–189
Weight, kg 22 113.0 (16.13) 83.5–148.0 68 81.3 (15.51) 50.6–123.5
Systolic BP, mmHg 22 126.0 (11.36) 112–159 68 137.0 (22.07) 96–213
Diastolic BP, mmHg 22 74.0 (8.16) 62–94 68 78.0 (8.42) 50–102
BMI, kg/m2 22 41.8 (5.66) 31.8–52.7 68 28.0 (5.35) 19.3–45.6
HOMA1-IR 22 2.5 (1.75) 0.8–6.5 65 0.8 (3.18) 0.2–25.5
WBISI 22 0.3 (0.77) 0.03–2.9 0 - -
AST, U/L 22 18.0 (9.32) 12.0–53.0 66 29.5 (1.23) 14.0–71.0
ALT, U/L 4 38.5 (6.70) 29.0–45.0 66 39.0 (20.36) 14.0–102.0
γ-GT, U/L 21 29.0 (45.72) 13.0–198.0 65 82.0 (82.74) 14.0–398.0
ALP, U/L 4 88.0 (9.22) 80.0–99.0 66 81.0 (38.96) 36.0–322.0
  1. SD Standard Deviation, BP Blood Pressure, BMI Body Mass Index, HOMA1-IR Homeostasis Model Assessment of Insulin Resistance 1, WBISI Whole Body Insulin Sensitivity Index, AST Aspartate Aminotransferase, ALT Alanine Aminotransferase, γ-GT Gamma-Glutamyl Transferase, ALP Alkaline Phosphatase